Alternate dosing regimens of brentuximab vedotin for Cd30+ cutaneous T‐cell lymphoma

DOI: 10.1111/bjd.15970

,

Issn Print: 0007-0963

Publication Date: 2018/01/01

Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T‐cell lymphoma

D.J. Lewis; Y.H. Kim; M. Duvic

Author Information: School of Medicine


		Checking for direct PDF access through Ovid

View on Journal Site

Abstract unavailable for this article.


		Loading Related Articles